TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
107
|
104
|
112 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
18
|
33
|
28 |
| EBITDA |
17
|
31
|
28 |
| Total assets |
159
|
162
|
185 |
| Current assets |
113
|
136
|
172 |
| Current liabilities |
18
|
6
|
9 |
| Equity capital |
130
|
147
|
153 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.8%
|
90.7%
|
82.7% |
| Turnover per employee |
107
|
104
|
112 |
| Profit as a percentage of turnover |
16.8%
|
31.7%
|
25.0% |
| Return on assets (ROA) |
11.3%
|
20.4%
|
15.1% |
| Current ratio |
627.8%
|
2266.7%
|
1911.1% |
| Return on equity (ROE) |
13.8%
|
22.4%
|
18.3% |
| Change turnover |
3
|
1
|
-35 |
| Change turnover % |
2%
|
1%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.